Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Net Margin: 2010-2012

Historic Net Margin for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -54.01%.

  • Sonoma Pharmaceuticals' Net Margin rose 3728.00% to -54.01% in Q4 2012 from the same period last year, while for Dec 2012 it was -34.71%, marking a year-over-year increase of 2409.00%. This contributed to the annual value of -58.02% for FY2012, which is 2305.00% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Net Margin stood at -54.01% for Q4 2012, which was down 123.04% from -24.22% recorded in Q3 2012.
  • Sonoma Pharmaceuticals' Net Margin's 5-year high stood at -15.23% during Q2 2012, with a 5-year trough of -108.44% in Q2 2010.
  • For the 3-year period, Sonoma Pharmaceuticals' Net Margin averaged around -60.37%, with its median value being -56.66% (2011).
  • Over the last 5 years, Sonoma Pharmaceuticals' Net Margin had its largest YoY gain of 5,875bps in 2012, and its largest YoY loss of 76bps in 2012.
  • Sonoma Pharmaceuticals' Net Margin (Quarterly) stood at -94.47% in 2010, then surged by 318bps to -91.29% in 2011, then surged by 3,728bps to -54.01% in 2012.
  • Its Net Margin stands at -54.01% for Q4 2012, versus -24.22% for Q3 2012 and -15.23% for Q2 2012.